Media

2018-02-24

IPO ALERT: Laurus Labs Ltd.

LAURUS LABS LIMITED

1. IPO DETAILS

COMPANY: LAURUS LABS LIMITED

 

SECTOR: PHARMACEUTICALS

 

IPO LOT SIZE: 35 SHARES PER APPLN.

 

PRICE BAND: INR 426 - INR 428

 

MIN. APP. SIZE: INR 14,980.00 (NO RET. DISC)

 

DATE: 6 - 8 DECEMBER 2016

 

2. Company Background

Incorporated in 2005, Laurus Labs Ltd. is Hyderabad based pharmaceutical

company. Laurus Labs is in the business of manufacturing generic active

pharmaceutical ingredients (APIs) for therapeutic areas of antiretrovirals (ARVs) and

Hepatitis C. Company also manufacture APIs in oncology and other therapeutic areas.

Company’s strategic and early investments in R&D and manufacturing infrastructure

has enabled it to become one of the leading suppliers of APIs in the ARV

therapeutic area to multi-national pharmaceutical formulation companies which

cater to the large and fast-growing “donor-funded access-to medicines markets” of

Sub-Saharan Africa, South-East Asia and Latin America. During the financial year

2016, LLL sold its APIs in 32 countries. The company also has growing synthesis

and nutraceutical/cosmeceutical ingredients businesses.